3rd Quarter - Report

CROSSROADS STRATEGIES, LLC for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about sickle cell disease therapy.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about sickle cell disease therapy.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs. Education about non-opioid pain therapies. S.3832/H.R.7142, Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 7142 (118th), S. 3832 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.